0001627223-16-000124.txt : 20160705 0001627223-16-000124.hdr.sgml : 20160705 20160705215510 ACCESSION NUMBER: 0001627223-16-000124 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160705 DATE AS OF CHANGE: 20160705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19899 BUSINESS PHONE: 302-773-1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19899 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRAWFORD CURTIS J CENTRAL INDEX KEY: 0001014318 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 161752418 MAIL ADDRESS: STREET 1: C/O XYLEM INC. STREET 2: 1133 WESTCHESTER AVENUE, SUITE N200 CITY: WHITE PLAINS STATE: NY ZIP: 10604 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2016-06-30 2016-07-01 0 0001627223 Chemours Co CC 0001014318 CRAWFORD CURTIS J C/O THE CHEMOURS COMPANY 1007 MARKET STREET WILMINGTON DE 19899 1 0 0 0 Common Stock 2016-06-30 4 J 0 8264.0107 8.24 D 53827 D Common Stock 47 I By Trust Stock Units 2016-06-30 4 A 0 1516.9902 8.24 A Common Stock 1516.9902 11889.5536 D Includes restricted stock units and dividend equivalent units. Units convert one-for-one to Chemours common stock. Credited under the Chemours deferred compensation plan for directors. This amendment revises the number of derivative securities acquired. Payable upon separation from service. Includes stock units and dividend equivalent units. This disposition related to investments under one or more deferred compensation/benefit plans of E. I. du Pont de Nemours and Company ("DuPont") that the reporting person participated in when he was a director of DuPont. Following Chemours' separation from DuPont on July 1, 2015, Chemours stock remained as an investment option under the DuPont plans until June 30, 2016. On June 30, 2016, the reporting person's investment was automatically allocated to other investment options according to the terms of the DuPont plans. The reporting person did not sell shares of Chemours stock as part of this transaction. /s/ Brian Morrissey, as attorney-in-fact for Curtis J. Crawford 2016-07-05